Repurposing ospemifene for potentiating an antigen-specific immune response.

about

Repurposing ospemifene for potentiating an antigen-specific immune response.

Item

http://www.wikidata.org/entity/Q46901671

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Repurposing ospemifene for potentiating an antigen-specific immune response.

@en

Repurposing ospemifene for potentiating an antigen-specific immune response.

@nl

type

Item

label

Repurposing ospemifene for potentiating an antigen-specific immune response.

@en

Repurposing ospemifene for potentiating an antigen-specific immune response.

@nl

prefLabel

Repurposing ospemifene for potentiating an antigen-specific immune response.

@en

Repurposing ospemifene for potentiating an antigen-specific immune response.

@nl

P1476

Repurposing ospemifene for potentiating an antigen-specific immune response.

@en

P2093

Brian Phong

http://www.w3.org/2001/XMLSchema#string

Chiao-Jung Kao

http://www.w3.org/2001/XMLSchema#string

Daniel P Vang

http://www.w3.org/2001/XMLSchema#string

Gregory T Wurz

http://www.w3.org/2001/XMLSchema#string

Michael W DeGregorio

http://www.w3.org/2001/XMLSchema#string

Yi-Chen Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller

Thalidomide is an inhibitor of angiogenesis

Modulation of T Cell Metabolism and Function through Calcium Signaling

The role of regulatory T cells in cancer immunology

Lung cancer vaccines: current status and future prospects

Dose translation from animal to human studies revisited

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma

CD27 is required for generation and long-term maintenance of T cell immunity.

The effects of tamoxifen on immunity.

Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.

P304

437-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/GME.0000000000000776

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27922937

http://www.w3.org/2001/XMLSchema#string

P932

5365365

http://www.w3.org/2001/XMLSchema#string